Big head? Bald head! Skull expansion: alternative model for the primary mechanism of AGA

Medical Hypotheses

Volumn 72, Issue 1, 2009, Pages 23-28

  Taylor, Paul J ^a  

^a Orpington   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN RECEPTOR; ANDROSTANOLONE; FINASTERIDE; OXIDOREDUCTASE; STEROID 5ALPHA REDUCTASE;

ARTICLE; BLOOD PRESSURE MEASUREMENT; BONE EXAMINATION; BONE REMODELING; CAPILLARY BLOOD; CAPILLARY FLOW; CELL PROLIFERATION; ENZYME ACTIVITY; FACE; FRONTAL BONE; GENE EXPRESSION; GENETIC PREDISPOSITION; HAIR FOLLICLE; HAIR GROWTH; HORMONAL REGULATION; HORMONE DETERMINATION; HUMAN; MALE TYPE ALOPECIA; OSSIFICATION; OSTEOBLAST; OSTEOLYSIS; PRIORITY JOURNAL; SCALP; SEBUM SECRETION; SKULL; SKULL DEVELOPMENT; SKULL RADIOGRAPHY;

ALOPECIA; HEAD; HUMANS; MALE; MODELS, BIOLOGICAL; MODELS, NEUROLOGICAL; RECEPTORS, ANDROGEN; SCALP; SKULL;

EID: 56249096511     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mehy.2008.07.048     Document Type: Article

References (23)

1. Ellis J.A., Stebbing M., and Harrap S.B. Polymorphism of the androgen receptor gene is associated with male pattern baldness. J Invest Dermatol 116 (2001) 452-455
2. Whiting D.A. Male pattern hair loss: current understanding. Int J Dermatol 37 8 (1998) 561-566
3. Mellin T.N., Busch R.D., and Rasmusson G.H. Azasteroids as inhibitors of testosterone 5 alpha-reductase in mammalian skin. J Steroid Biochem Mol Bio 44 2 (1993) 121-131
4. Ellis J.A., Stebbing M., and Harrap S.B. Genetic analysis of male pattern baldness and the 5alpha-reductase genes. J Invest Dermatol 110 (1998) 849-853
5. Carey A.H., Waterworth D., Patel K., et al. Polycystic ovaries and premature male pattern baldness are associated with one allele of the steroid metabolism gene CYP17. Hum Mol Genet 3 10 (1994) 1873-1876
6. Richard MJ. Clues to wrinkles may be found in facial bone structure. Retrieved 10 October 2007. .
7. Gray H. Anatomy of the human body, 20th ed. W.H. Lewis, New York, Bartleby.com, 2000. Retrieved 14 June 2008. par. 2, 9.
8. Gray H. Anatomy of the human body, 20th ed. W.H. Lewis, New York, Bartleby.com, 2000. Retrieved 14 June 2008. par. 2, 6.
9. In: Kumar P.J., and Clark M.L. (Eds). Clinical medicine. 4th ed. (1998), W.B. Saunders, Edinburgh pp. 502-503
10. Janowiak JJ, Ham C. A practitioner's guide to hair loss: part 1 - history, biology, genetics, prevention, conventional treatments, and herbals, 2004. Retrieved 10 October 2007. .
11. New Zealand Dermatological Society Incorporated, Sebum, 2006. Retrieved 16 June 2008. .
12. Abu E.O., Horner A., Kusec V., Triffitt J.T., and Compston J.E. The localization of androgen receptors in human bone. J Clin Endocrinol Metab 82 10 (1997) 3493-3497
13. Riedel-Baima B., and Riedel A. Female pattern hair loss may be triggered by low oestrogen to androgen ratio. Endocr Regul 42 1 (2008) 13-16
14. Gori F., Hofbauer L.C., Conover C.A., and Khosler S. Effects of androgens on the insulin-like growth factor system in an androgen-responsive human osteoblastic cell line. Endocrinology 140 12 (1999) 5579-5586
15. Aschaiek S, Bendall L, Grant G, et al. Alopecia: the facts. Retrieved 20 June 2008. .
16. Tosti A., Iorizzo M., and Piraccini B.M. Androgenetic alopecia in children: report of 20 cases. Br J Dermatol 152 3 (2005) 556-559
17. Sinclair R. Male pattern androgenetic alopecia. BMJ 317 7162 (1998) 865-869
18. Randall V.A., Hibberts N.A., Thornton M.J., et al. Do androgens influence hair growth by altering the paracrine factors secreted by dermal papilla cells?. EJD 11 4 (2001) 315-320
19. Kaufman K.D., and Dawber R.P. Finasteride, a type 2 5α-reductase inhibitor, in the treatment of men with androgenetic alopecia. Expert opinion on investigational drugs 8 4 (1999) 403-415
20. Asada Y., Sonoda T., Ojiro M., et al. 5α-reductase type 2 is constitutively expressed in the dermal papilla and connective tissue sheath of the hair follicle in vivo but not during culture in vitro. J Clin Endocrinol Metab 86 6 (2001) 2875-2880
21. Issa S., Schnabel D., Feix M., et al. Human osteoblast-like cells express predominantly steroid 5α-reductase type 1. J Clin Endocrinol Metab 87 12 (2002) 5401-5407
22. Drake L., Hordinsky M., Fiedler V.S., et al. The effects of finasteride on scalp skin and serum androgen levels in men with androgenetic alopecia. J Am Acad Dermatol 41 4 (1999) 550-554
23. Matilainen V., Laakso M., et al. Hair loss, insulin resistance, and heredity in middle-aged women. A population-based study. J Cardiovasc Risk 10 3 (2003) 227-231